Biosecurity Kennisdag

Biosecurity Kennisdag       Landelijke Functionaliteit Infectieziekten (LFI)       Human medicines European public assessment report (EPAR): Kymriah, tisagenlecleucel, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;Lymphoma, Large B-Cell, Diffuse, Date of authorisation: 22/08/2018, Revision: 12, Status: Authorised Human medicines European public assessment report (EPAR): Kymriah, tisagenlecleucel, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;Lymphoma, Large B-Cell, Diffuse, Date of authorisation: 22/08/2018, Revision: 12, Status: Authorised       Laboratory support for SARS-CoV-2 virus neutralisation in the EU/EEA - a pilot study This report presents the results of a pilot study aimed at assisting EU/EEA countries with SARS-CoV-2 antigenic characterisation.

Actueel zorgnieuws in jouw mailbox ontvangen?

Direct het hele artikel lezen? Meld je aan voor de nieuwsbrief.